Opium - Poppy Cultivation, Morphine and Heroin …
Dr. Liz-Marzán has been the recipient of several awards, including an ERC Advanced Grant, the Rey Jaime I Award on Basic Research, Medal of the Spanish Royal Society of Chemistry, ECIS Rhodia Prize, ACS Nano Lectureship Award, Langmuir Lecturer, and DuPont Award for Science. He is a Member of the Spanish Royal Academy of Sciences, Fellow of the Royal Society of Chemistry, and Fellow of the Optical Society of America. Dr. Liz-Marzán has also been named as one of ISI’s Highly Cited Researchers in both Chemistry and Materials Science.
December « 2017 « New Drug Approvals
Veronique started her independent research career at the University of Oxford in 1998 in the Chemistry Faculty and was promoted to Professor of Chemistry in 2008. Her research aims at developing new approaches to address long-standing problems in the synthesis of fluorinated molecules including pharmaceutical drugs and probes for imaging (Positron Emission Tomography). To date, she has mentored more than 30 Postdocs and supervised 40 PhD (= DPhil in Oxford) to completion.
Ernst Wagner, PhD in chemistry in 1985 from TU Vienna, full professor of Pharmaceutical Biotechnology at LMU Munich since 2001, is member of the Center for Nanoscience (CeNS), and executive board member of the Cluster of Excellence ‘Nanosystems Initiative Munich’, contributing to polymer-based delivery systems for thirty years. Since 1988 as Group Leader at IMP Vienna, he developed synthetic virus-like gene transfer, including adenovirus-enhanced transferrinfection (AVET), which led to the first-in-world polymer-based gene therapy study (IL-2 gene-modified cancer vaccines) in 1994, developed under his function as Director for Cancer Vaccines at Boehringer Ingelheim Austria (1992-2001). His current research focuses on chemical evolution of sequence-defined carriers for drugs, proteins and therapeutic nucleic acids, with a medical focus on tumor-targeted therapies. He has authored ≥420 publications (h-index 75), is Editor-in Chief of The Journal of Gene Medicine, Editor of Pharmaceutical Research, board member of the German Society for Gene Therapy, committee member of the American Society of Gene and Cell Therapy (ASGCT), invited guest professor at Utrecht University (1996), Fudan University (Shanghai 2012-13), Sichuan University (Chengdu 2014-17), and was awarded with the Attocube research award, Phoenix Pharma Science award, and the election into CRS College of Fellows.